当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3695925
自主品牌
已选条件
-
T4341BetrixabanBetrixaban,PRT-054021,Factor Xa,inhibit,Fxa,PRT 054021,Inhibitor
Betrixaban is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa [1]. It was selected among all lead compounds due to its low hERG channel affinity while sustaining its factor Xa inhibition capacity [3]. Betrixaban, now developed by Portola Pharmaceuticals Inc., is prescribed as a venous thromboembolism (VTE) prophylactic for adult patients with moderate to severe restricted motility or with other risks for VTE [2]. VTE can be
价 格：￥电议型 号：T4341产 地：中国大陆
-
T4980Betrixaban maleate
Betrixaban is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa [1]. It was selected among all lead compounds due to its low hERG channel affinity while sustaining its factor Xa inhibit
价 格：￥电议型 号：T4980产 地：中国大陆
-
T4690Betrixaban hydrochloride(330942-05-7(free base))盐酸贝曲西班；PRT054021 hydrochloride
Betrixaban is a potent, selective, and orally efficacious factor Xa (fXa) inhibitor (IC50: 1.5 nM).
价 格：￥电议型 号：T4690产 地：中国大陆
-
T4980Betrixaban maleateBetrixaban maleate
Betrixaban is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa [1]. It was selected among all lead compounds due to its low hERG channel affinity while sustaining its factor Xa inhibit
价 格：￥电议型 号：T4980产 地：美洲
-
T4980Betrixaban maleate；贝曲西班马来酸盐Betrixaban maleate
Betrixaban is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa [1]. It was selected among all lead compounds due to its low hERG channel affinity while sustaining its factor Xa inhibition capacity [3]. Betrixaban, now developed by Portola Pharmaceuticals Inc., is prescribed as a venous thromboembolism (VTE) prophylactic for adult patients with moderate to severe restricted motility or with other risks for VTE [2]. VTE can be
价 格：￥电议型 号：T4980产 地：中国大陆
-
T4690Betrixaban hydrochloride(330942-05-7(free base))；盐酸贝曲西班PRT054021 hydrochloride；PRT054021 hydrochlori
Betrixaban hydrochloride(330942-05-7(free base)) (PRT054021 hydrochloride) is a potent, selective, and orally efficacious factor Xa (fXa) inhibitor (IC50: 1.5 nM).
价 格：￥电议型 号：T4690产 地：中国大陆
-
T4341Betrixaban；贝曲西班PRT054021；贝曲西班|||PRT054021
Betrixaban (PRT054021) is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa [1]. It was selected among all lead compounds due to its low hERG channel affinity while sustaining its factor Xa inhibition capacity [3]. Betrixaban, now developed by Portola Pharmaceuticals Inc., is prescribed as a venous thromboembolism (VTE) prophylactic for adult patients with moderate to severe restricted motility or with other risks for VTE [2].
价 格：￥电议型 号：T4341产 地：中国大陆
-
T10527Betrixaban-d6；化合物 T10527Betrixaban D6；Betrixaban D6
Betrixaban D6 is a deuterium-labeled Betrixaban. Betrixaban is a selective and orally efficacious FXa inhibitor.
价 格：￥电议型 号：T10527产 地：中国大陆
